Statera BioPharma Inc

STU:7CB (USA)   Ordinary Shares
€ 0.00 (0%) Dec 31
At Loss
Market Cap:
€ 40.00K ($ 43.00K)
Enterprise V:
€ - ($ -)
Volume:
-
Avg Vol (2M):
-
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Statera BioPharma Inc ( STU:7CB ) from 2021 to Jun 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Statera BioPharma stock (STU:7CB) PE ratio as of Jun 17 2024 is 0. More Details

Statera BioPharma Inc (STU:7CB) PE Ratio (TTM) Chart

To

Statera BioPharma Inc (STU:7CB) PE Ratio (TTM) Historical Data

Total 0
  • 1
Statera BioPharma PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Statera BioPharma Inc (STU:7CB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Statera BioPharma Inc
NAICS : 325412 SIC : 2834

Share Class Description:

STU:7CB: Ordinary Shares
Description
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.